KEN MENDOZA

From systems architect to healthcare innovator, Ken Mendoza's journey began in the trenches of Silicon Valley tech companies, where he learned to build scalable systems and navigate the complex path from innovation to IPO. His technical foundation spans 25+ years of AI and software development, including leadership roles that culminated in a successful NASDAQ public offering.

The defining moment came during a deeply personal health crisis experienced by Ken's soulmate and the love of his life, Toni. Her medical journey—a relentless series of more than a hundred complex tests involving numerous specialists—ultimately led to the diagnoses of both a brain tumor and autoimmune disease, conditions that had previously gone undetected. This transformative experience exposed fundamental gaps in medical information management and care coordination, inspiring Ken's mission to revolutionize healthcare through AI and fueling the creation of MedAdvocate.

Today, Ken operates at the unique intersection of deep biomedical science, scalable software architecture, and defensible intellectual property. His work spans from computational immunology research exploring Polly Matzinger's Danger Theory to building AI-powered clinical tools.

With 5 patents in proteomics and extensive experience in drug target identification, Ken brings a rare combination of scientific rigor, technical execution, and venture leadership to the next generation of healthcare innovation.